Abstract
Purpose. The aim of this study was to reduce or prevent nonspecific binding (NSB) of compounds to ultrafiltration (UF) protein binding (PB) testing units.
Methods. UF units (regenerated cellulose, MWCO 10K) were used for PB and NSB measurements with or without pretreatment with 5% tween 80 (TW 80) or 5% benzalkonium chloride (BAK) on the filter membrane. Dosing solutions (10 μM) in human serum and pH 7.4 phosphate-buffered saline were centrifuged at 3,000 g and room temperature after 1-h incubation in UF testing units. In parallel, a 96-well equilibrium dialyzer was used for PB and NSB measurements in equilibrium dialysis (ED) at 37°C for 4 h. Samples of UF and ED were analyzed by LC/MS or LSC.
Results. Severe NSB was observed for etoposide, hydrocortisone, propranolol, and vinblastine in UF. In contrast, TW 80 or BAK pretreatment on the filter membrane decreased the NSB from 87-95% to 13-64% without causing a significant change in membrane integrity. When NSB was below 50% as a result of pretreating agents, PB data of marker compounds were comparable to those of ED.
Conclusions. The pretreated membrane with TW 80 or BAK showed significantly less NSB for compounds that had a tendency toward high membrane binding. A modified UF method with pretreatment improved the performance of UF and was able to produce comparable PB results to ED.
Similar content being viewed by others
REFERENCES
L. Shargel and A. B. C. Yu. Applied Biopharmaceutics and Pharmacokinetic, 4th ed., Appleton & Lange, Stamford, Connecticut, 1999.
G. M. Pacifici and A. Viani. Methods of determining plasma and tissue binding of drugs. Clin. Pharmacokinet. 23:449–468 (1992).
J. Schuhmacher, K. Buhner, and A. Witt-Laido. Determination of the free fraction and relative free fraction of drugs strongly bound to plasma proteins. J. Pharm. Sci. 89:1008–1021 (2000).
L. Z. Benet and B. Hoener. Changes in plasma protein binding have little clinical relevance. Clin. Pharmacol. Ther. 71:115–121 (2002).
P. H. Hinderling, J. Bres, and E. R. Garret. Protein binding and erythrocyte partitioning of disopyramide and its monodealkylated metabolite. J. Pharm. Sci. 63:1684–1690 (1974).
J. B. Whitlam and K. F. Brown. Ultrafiltration in serum protein binding determinations. J. Pharm. Sci. 70:146–150 (1981).
R. A. R. Tasker and K. Nakatsu. Factors affecting ultrafiltration-assessed values for drug binding. Clin. Chem. 28:1244–1246 (1982).
Y. Zhirkov and V. K. Piotrovskii. On the usefulness of ultrafiltration in drug-protein binding studies. J. Pharm. Pharmacol. 36:844–845 (1984).
B. Sebille. Methods of drug protein binding determinations. Fundam. Clin. Pharmacol. 4(Suppl. 2):151s-161s (1990).
I. Kariv, H. Cao, and K. R. Oldenburg. Development of a high throughput equilibrium dialysis method. J. Pharm. Sci. 90:580–587 (2001).
S. Gedon and R. Fengl. Cellulose esters: Organic esters. In Kirk-Othmer Encyclopedia of Chemical Technology, 4th ed., Wiley-Interscience, New York, 1993, pp. 496–529.
T. C. Kwong. Free drug measurements: methodology and clinical significance. Clin. Chim. Acta 151:193–216 (1985).
J. Yuan, D. C. Yang, J. Birkmeier, and J. Stolzenbach. Determination of protein binding by in vitro charcoal adsorption. J. Pharmacokinet. Biopharm. 23:41–55 (1995).
A. Shibukawa, Y. Kuroda, and T. Nakagawa. High performance frontal analysis for drug–protein binding study. J. Pharm. Biomed. Anal. 18:1047–1055 (1999).
J. Blanchard and S. Harvey. Comparison of ultrafiltration devices for assessing theophylline protein binding. Ther. Drug Monit. 12:398–403 (1990).
H. Kurz, H. Trunk, and B. Weitz. Evaluation of methods to determine protein-binding of drugs. Arzneim.-Forsch. 27:1373–1380 (1977).
H. R. Ha, S. Vozeh, and F. Follath. Evaluation of a rapid ultrafiltration technique for determination of quinidine protein binding and comparison with equilibrium dialysis. Ther. Drug Monit. 8:331–335 (1986).
L. Bertilsson, R. Braithwaite, G. Tybring, M. Garle, and O. Borga. Techniques for plasma protein binding of demethylchlorimipramine. Clin. Pharmacol. Ther. 26:265–271 (1979).
D. Jung, M. Mayersohn, and D. Perrier. The "ultra-free" ultrafiltration technique compared with equilibrium dialysis for determination of unbound thiopental concentrations in serum. Clin. Chem. 27:166–168 (1981).
L. M. Shaw, R. Altman, B. C. Thompson, and L. Fields. Factors affecting the binding of disopyramide to serum proteins. Clin. Chem. 31:616–619 (1985).
B. M. David, R. Tjokrosetio, and K. F. Ilett. Plasma protein binding of disopyramide by equilibrium dialysis and ultrafiltration. Ther. Drug Monit. 5:81–86 (1983).
W. Scholtan. Determination of protein binding of sulfonamides by means of ultracentrifuge and gel filtration. Arzneim.-Forsch. 15:1433–1441 (1965).
P. M. Keen. The binding of penicillins to bovine serum albumin. Biochem. Pharmacol. 15:447–463 (1966).
C. Tanford. Physical Chemistry of Macromolecules. John Wiley & Sons, New York, 1961.
P. Suter and J. P. Rosenbusch. Determination of the Donnan effect in equilibrium dialysis and a simple method for its correction. Anal. Biochem. 82:109–114 (1977).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, KJ., Mower, R., Hollenbeck, T. et al. Modulation of Nonspecific Binding in Ultrafiltration Protein Binding Studies. Pharm Res 20, 1015–1021 (2003). https://doi.org/10.1023/A:1024406221962
Issue Date:
DOI: https://doi.org/10.1023/A:1024406221962